Global Parkinson's Disease Treatments Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Parkinson?s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
SCOPE OF THE REPORT:
The worldwide market for Parkinson's Disease Treatments is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Parkinson's Disease Treatments in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Parkinson's Disease Treatments Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Parkinson's Disease Treatments, with sales, revenue, and price of Parkinson's Disease Treatments, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Parkinson's Disease Treatments, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Parkinson's Disease Treatments market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Parkinson's Disease Treatments sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
SCOPE OF THE REPORT:
The worldwide market for Parkinson's Disease Treatments is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Parkinson's Disease Treatments in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- GSK
- Merck
- Novartis
- Teva
- Boehringer Ingelheim
- Impax
- Abbvie
- Valeant Pharmaceuticals
- Lundbeck
- Sun Pharma
- Wockhardt
- Acadia
- UCB
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Dopamine Agonists
- Levodopa
- Glutamate Antagonist
- Apomorphine
- COMT Inhibitors Anticholinergics
- MAO-B Inhibitors
- Other Drugs
- Hospitals
- Healthcare Institutes
- Others
Chapter 1, to describe Parkinson's Disease Treatments Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Parkinson's Disease Treatments, with sales, revenue, and price of Parkinson's Disease Treatments, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Parkinson's Disease Treatments, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Parkinson's Disease Treatments market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Parkinson's Disease Treatments sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Parkinson's Disease Treatments Introduction
1.2 Market Analysis by Type
1.2.1 Dopamine Agonists
1.2.2 Levodopa
1.2.3 Glutamate Antagonist
1.2.4 Apomorphine
1.2.5 COMT Inhibitors Anticholinergics
1.2.6 MAO-B Inhibitors
1.2.7 Other Drugs
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Healthcare Institutes
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 Business Overview
2.1.2 Parkinson's Disease Treatments Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Parkinson's Disease Treatments Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Parkinson's Disease Treatments Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva
2.4.1 Business Overview
2.4.2 Parkinson's Disease Treatments Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Parkinson's Disease Treatments Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Impax
2.6.1 Business Overview
2.6.2 Parkinson's Disease Treatments Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Impax Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbvie
2.7.1 Business Overview
2.7.2 Parkinson's Disease Treatments Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbvie Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Valeant Pharmaceuticals
2.8.1 Business Overview
2.8.2 Parkinson's Disease Treatments Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lundbeck
2.9.1 Business Overview
2.9.2 Parkinson's Disease Treatments Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lundbeck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharma
2.10.1 Business Overview
2.10.2 Parkinson's Disease Treatments Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharma Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Wockhardt
2.11.1 Business Overview
2.11.2 Parkinson's Disease Treatments Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Wockhardt Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Acadia
2.12.1 Business Overview
2.12.2 Parkinson's Disease Treatments Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Acadia Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 UCB
2.13.1 Business Overview
2.13.2 Parkinson's Disease Treatments Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 UCB Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL PARKINSON'S DISEASE TREATMENTS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Parkinson's Disease Treatments Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Parkinson's Disease Treatments Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Parkinson's Disease Treatments Manufacturer Market Share in 2017
3.3.2 Top 6 Parkinson's Disease Treatments Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET ANALYSIS BY REGIONS
4.1 Global Parkinson's Disease Treatments Sales, Revenue and Market Share by Regions
4.1.1 Global Parkinson's Disease Treatments Sales and Market Share by Regions (2013-2018)
4.1.2 Global Parkinson's Disease Treatments Revenue and Market Share by Regions (2013-2018)
4.2 North America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.3 Europe Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.5 South America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
5 NORTH AMERICA PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
5.1 North America Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
5.1.1 North America Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
5.1.2 North America Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
5.2 United States Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
5.3 Canada Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
5.4 Mexico Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6 EUROPE PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
6.1 Europe Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
6.1.1 Europe Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
6.2 Germany Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.3 UK Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.4 France Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.5 Russia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.6 Italy Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
7.1 Asia-Pacific Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
7.2 China Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.3 Japan Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.4 Korea Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.5 India Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
8.1 South America Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
8.1.1 South America Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
8.1.2 South America Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
8.3 Argentina Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
8.4 Colombia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
9.1 Middle East and Africa Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.3 UAE Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.4 Egypt Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.5 Nigeria Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.6 South Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
10 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET SEGMENT BY TYPE
10.1 Global Parkinson's Disease Treatments Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Parkinson's Disease Treatments Sales and Market Share by Type (2013-2018)
10.1.2 Global Parkinson's Disease Treatments Revenue and Market Share by Type (2013-2018)
10.2 Dopamine Agonists Sales Growth and Price
10.2.1 Global Dopamine Agonists Sales Growth (2013-2018)
10.2.2 Global Dopamine Agonists Price (2013-2018)
10.3 Levodopa Sales Growth and Price
10.3.1 Global Levodopa Sales Growth (2013-2018)
10.3.2 Global Levodopa Price (2013-2018)
10.4 Glutamate Antagonist Sales Growth and Price
10.4.1 Global Glutamate Antagonist Sales Growth (2013-2018)
10.4.2 Global Glutamate Antagonist Price (2013-2018)
10.5 Apomorphine Sales Growth and Price
10.5.1 Global Apomorphine Sales Growth (2013-2018)
10.5.2 Global Apomorphine Price (2013-2018)
10.6 COMT Inhibitors Anticholinergics Sales Growth and Price
10.6.1 Global COMT Inhibitors Anticholinergics Sales Growth (2013-2018)
10.6.2 Global COMT Inhibitors Anticholinergics Price (2013-2018)
10.7 MAO-B Inhibitors Sales Growth and Price
10.7.1 Global MAO-B Inhibitors Sales Growth (2013-2018)
10.7.2 Global MAO-B Inhibitors Price (2013-2018)
10.8 Other Drugs Sales Growth and Price
10.8.1 Global Other Drugs Sales Growth (2013-2018)
10.8.2 Global Other Drugs Price (2013-2018)
11 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET SEGMENT BY APPLICATION
11.1 Global Parkinson's Disease Treatments Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Healthcare Institutes Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 PARKINSON'S DISEASE TREATMENTS MARKET FORECAST (2018-2023)
12.1 Global Parkinson's Disease Treatments Sales, Revenue and Growth Rate (2018-2023)
12.2 Parkinson's Disease Treatments Market Forecast by Regions (2018-2023)
12.2.1 North America Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.2 Europe Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.3 Asia-Pacific Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.4 South America Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.5 Middle East and Africa Parkinson's Disease Treatments Market Forecast (2018-2023)
12.3 Parkinson's Disease Treatments Market Forecast by Type (2018-2023)
12.3.1 Global Parkinson's Disease Treatments Sales Forecast by Type (2018-2023)
12.3.2 Global Parkinson's Disease Treatments Market Share Forecast by Type (2018-2023)
12.4 Parkinson's Disease Treatments Market Forecast by Application (2018-2023)
12.4.1 Global Parkinson's Disease Treatments Sales Forecast by Application (2018-2023)
12.4.2 Global Parkinson's Disease Treatments Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Parkinson's Disease Treatments Introduction
1.2 Market Analysis by Type
1.2.1 Dopamine Agonists
1.2.2 Levodopa
1.2.3 Glutamate Antagonist
1.2.4 Apomorphine
1.2.5 COMT Inhibitors Anticholinergics
1.2.6 MAO-B Inhibitors
1.2.7 Other Drugs
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Healthcare Institutes
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 Business Overview
2.1.2 Parkinson's Disease Treatments Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Parkinson's Disease Treatments Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Parkinson's Disease Treatments Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva
2.4.1 Business Overview
2.4.2 Parkinson's Disease Treatments Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Parkinson's Disease Treatments Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Impax
2.6.1 Business Overview
2.6.2 Parkinson's Disease Treatments Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Impax Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbvie
2.7.1 Business Overview
2.7.2 Parkinson's Disease Treatments Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbvie Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Valeant Pharmaceuticals
2.8.1 Business Overview
2.8.2 Parkinson's Disease Treatments Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lundbeck
2.9.1 Business Overview
2.9.2 Parkinson's Disease Treatments Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lundbeck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharma
2.10.1 Business Overview
2.10.2 Parkinson's Disease Treatments Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharma Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Wockhardt
2.11.1 Business Overview
2.11.2 Parkinson's Disease Treatments Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Wockhardt Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Acadia
2.12.1 Business Overview
2.12.2 Parkinson's Disease Treatments Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Acadia Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 UCB
2.13.1 Business Overview
2.13.2 Parkinson's Disease Treatments Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 UCB Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL PARKINSON'S DISEASE TREATMENTS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Parkinson's Disease Treatments Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Parkinson's Disease Treatments Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Parkinson's Disease Treatments Manufacturer Market Share in 2017
3.3.2 Top 6 Parkinson's Disease Treatments Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET ANALYSIS BY REGIONS
4.1 Global Parkinson's Disease Treatments Sales, Revenue and Market Share by Regions
4.1.1 Global Parkinson's Disease Treatments Sales and Market Share by Regions (2013-2018)
4.1.2 Global Parkinson's Disease Treatments Revenue and Market Share by Regions (2013-2018)
4.2 North America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.3 Europe Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.5 South America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
5 NORTH AMERICA PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
5.1 North America Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
5.1.1 North America Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
5.1.2 North America Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
5.2 United States Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
5.3 Canada Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
5.4 Mexico Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6 EUROPE PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
6.1 Europe Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
6.1.1 Europe Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
6.2 Germany Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.3 UK Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.4 France Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.5 Russia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
6.6 Italy Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
7.1 Asia-Pacific Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
7.2 China Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.3 Japan Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.4 Korea Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.5 India Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
8.1 South America Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
8.1.1 South America Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
8.1.2 South America Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
8.3 Argentina Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
8.4 Colombia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA PARKINSON'S DISEASE TREATMENTS BY COUNTRIES
9.1 Middle East and Africa Parkinson's Disease Treatments Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Parkinson's Disease Treatments Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Parkinson's Disease Treatments Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.3 UAE Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.4 Egypt Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.5 Nigeria Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
9.6 South Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
10 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET SEGMENT BY TYPE
10.1 Global Parkinson's Disease Treatments Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Parkinson's Disease Treatments Sales and Market Share by Type (2013-2018)
10.1.2 Global Parkinson's Disease Treatments Revenue and Market Share by Type (2013-2018)
10.2 Dopamine Agonists Sales Growth and Price
10.2.1 Global Dopamine Agonists Sales Growth (2013-2018)
10.2.2 Global Dopamine Agonists Price (2013-2018)
10.3 Levodopa Sales Growth and Price
10.3.1 Global Levodopa Sales Growth (2013-2018)
10.3.2 Global Levodopa Price (2013-2018)
10.4 Glutamate Antagonist Sales Growth and Price
10.4.1 Global Glutamate Antagonist Sales Growth (2013-2018)
10.4.2 Global Glutamate Antagonist Price (2013-2018)
10.5 Apomorphine Sales Growth and Price
10.5.1 Global Apomorphine Sales Growth (2013-2018)
10.5.2 Global Apomorphine Price (2013-2018)
10.6 COMT Inhibitors Anticholinergics Sales Growth and Price
10.6.1 Global COMT Inhibitors Anticholinergics Sales Growth (2013-2018)
10.6.2 Global COMT Inhibitors Anticholinergics Price (2013-2018)
10.7 MAO-B Inhibitors Sales Growth and Price
10.7.1 Global MAO-B Inhibitors Sales Growth (2013-2018)
10.7.2 Global MAO-B Inhibitors Price (2013-2018)
10.8 Other Drugs Sales Growth and Price
10.8.1 Global Other Drugs Sales Growth (2013-2018)
10.8.2 Global Other Drugs Price (2013-2018)
11 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET SEGMENT BY APPLICATION
11.1 Global Parkinson's Disease Treatments Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Healthcare Institutes Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 PARKINSON'S DISEASE TREATMENTS MARKET FORECAST (2018-2023)
12.1 Global Parkinson's Disease Treatments Sales, Revenue and Growth Rate (2018-2023)
12.2 Parkinson's Disease Treatments Market Forecast by Regions (2018-2023)
12.2.1 North America Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.2 Europe Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.3 Asia-Pacific Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.4 South America Parkinson's Disease Treatments Market Forecast (2018-2023)
12.2.5 Middle East and Africa Parkinson's Disease Treatments Market Forecast (2018-2023)
12.3 Parkinson's Disease Treatments Market Forecast by Type (2018-2023)
12.3.1 Global Parkinson's Disease Treatments Sales Forecast by Type (2018-2023)
12.3.2 Global Parkinson's Disease Treatments Market Share Forecast by Type (2018-2023)
12.4 Parkinson's Disease Treatments Market Forecast by Application (2018-2023)
12.4.1 Global Parkinson's Disease Treatments Sales Forecast by Application (2018-2023)
12.4.2 Global Parkinson's Disease Treatments Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Parkinson's Disease Treatments Picture
Table Product Specifications of Parkinson's Disease Treatments
Figure Global Sales Market Share of Parkinson's Disease Treatments by Types in 2017
Table Parkinson's Disease Treatments Types for Major Manufacturers
Figure Dopamine Agonists Picture
Figure Levodopa Picture
Figure Glutamate Antagonist Picture
Figure Apomorphine Picture
Figure COMT Inhibitors Anticholinergics Picture
Figure MAO-B Inhibitors Picture
Figure Other Drugs Picture
Figure Parkinson's Disease Treatments Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Healthcare Institutes Picture
Figure Others Picture
Figure United States Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure France Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure UK Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure China Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure India Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Parkinson's Disease Treatments Type and Applications
Table GSK Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Parkinson's Disease Treatments Type and Applications
Table Merck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Parkinson's Disease Treatments Type and Applications
Table Novartis Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Parkinson's Disease Treatments Type and Applications
Table Teva Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Parkinson's Disease Treatments Type and Applications
Table Boehringer Ingelheim Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Impax Basic Information, Manufacturing Base and Competitors
Table Impax Parkinson's Disease Treatments Type and Applications
Table Impax Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Parkinson's Disease Treatments Type and Applications
Table Abbvie Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Parkinson's Disease Treatments Type and Applications
Table Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lundbeck Basic Information, Manufacturing Base and Competitors
Table Lundbeck Parkinson's Disease Treatments Type and Applications
Table Lundbeck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Parkinson's Disease Treatments Type and Applications
Table Sun Pharma Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Parkinson's Disease Treatments Type and Applications
Table Wockhardt Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Acadia Basic Information, Manufacturing Base and Competitors
Table Acadia Parkinson's Disease Treatments Type and Applications
Table Acadia Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Parkinson's Disease Treatments Type and Applications
Table UCB Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Parkinson's Disease Treatments Sales by Manufacturer (2016-2017)
Figure Global Parkinson's Disease Treatments Sales Market Share by Manufacturer in 2016
Figure Global Parkinson's Disease Treatments Sales Market Share by Manufacturer in 2017
Table Global Parkinson's Disease Treatments Revenue by Manufacturer (2016-2017)
Figure Global Parkinson's Disease Treatments Revenue Market Share by Manufacturer in 2016
Figure Global Parkinson's Disease Treatments Revenue Market Share by Manufacturer in 2017
Figure Top 3 Parkinson's Disease Treatments Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Parkinson's Disease Treatments Manufacturer (Revenue) Market Share in 2017
Figure Global Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Global Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatments Sales by Regions (2013-2018)
Table Global Parkinson's Disease Treatments Sales Market Share by Regions (2013-2018)
Table Global Parkinson's Disease Treatments Revenue by Regions (2013-2018)
Figure Global Parkinson's Disease Treatments Revenue Market Share by Regions in 2013
Figure Global Parkinson's Disease Treatments Revenue Market Share by Regions in 2017
Figure North America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure South America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure North America Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table North America Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table North America Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatments Sales Market Share by Countries in 2013
Figure North America Parkinson's Disease Treatments Sales Market Share by Countries in 2017
Table North America Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Table North America Parkinson's Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatments Revenue Market Share by Countries in 2013
Figure North America Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure United States Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Canada Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Mexico Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Europe Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table Europe Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Table Europe Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatments Revenue Market Share by Countries in 2016
Figure Europe Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure Germany Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure UK Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure France Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Russia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Italy Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table Asia-Pacific Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Sales Market Share by Countries 2017
Table Asia-Pacific Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Revenue Market Share by Countries 2017
Figure China Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Japan Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Korea Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure India Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Southeast Asia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure South America Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table South America Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table South America Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatments Sales Market Share by Countries in 2017
Table South America Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Table South America Parkinson's Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure Brazil Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Argentina Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Colombia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Countries in 2017
Table Middle East and Africa Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries in 2013
Figure Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure Saudi Arabia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure UAE Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Egypt Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Nigeria Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure South Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatments Sales by Type (2013-2018)
Table Global Parkinson's Disease Treatments Sales Share by Type (2013-2018)
Table Global Parkinson's Disease Treatments Revenue by Type (2013-2018)
Table Global Parkinson's Disease Treatments Revenue Share by Type (2013-2018)
Figure Global Dopamine Agonists Sales Growth (2013-2018)
Figure Global Dopamine Agonists Price (2013-2018)
Figure Global Levodopa Sales Growth (2013-2018)
Figure Global Levodopa Price (2013-2018)
Figure Global Glutamate Antagonist Sales Growth (2013-2018)
Figure Global Glutamate Antagonist Price (2013-2018)
Figure Global Apomorphine Sales Growth (2013-2018)
Figure Global Apomorphine Price (2013-2018)
Figure Global COMT Inhibitors Anticholinergics Sales Growth (2013-2018)
Figure Global COMT Inhibitors Anticholinergics Price (2013-2018)
Figure Global MAO-B Inhibitors Sales Growth (2013-2018)
Figure Global MAO-B Inhibitors Price (2013-2018)
Figure Global Other Drugs Sales Growth (2013-2018)
Figure Global Other Drugs Price (2013-2018)
Table Global Parkinson's Disease Treatments Sales by Application (2013-2018)
Table Global Parkinson's Disease Treatments Sales Share by Application (2013-2018)
Figure Global Healthcare Institutes Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Parkinson's Disease Treatments Sales, Revenue and Growth Rate (2018-2023)
Table Global Parkinson's Disease Treatments Sales Forecast by Regions (2018-2023)
Table Global Parkinson's Disease Treatments Market Share Forecast by Regions (2018-2023)
Figure North America Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure Europe Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure Asia-Pacific Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure South America Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure Middle East and Africa Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Table Global Parkinson's Disease Treatments Sales Forecast by Type (2018-2023)
Table Global Parkinson's Disease Treatments Market Share Forecast by Type (2018-2023)
Table Global Parkinson's Disease Treatments Sales Forecast by Application (2018-2023)
Table Global Parkinson's Disease Treatments Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Parkinson's Disease Treatments Picture
Table Product Specifications of Parkinson's Disease Treatments
Figure Global Sales Market Share of Parkinson's Disease Treatments by Types in 2017
Table Parkinson's Disease Treatments Types for Major Manufacturers
Figure Dopamine Agonists Picture
Figure Levodopa Picture
Figure Glutamate Antagonist Picture
Figure Apomorphine Picture
Figure COMT Inhibitors Anticholinergics Picture
Figure MAO-B Inhibitors Picture
Figure Other Drugs Picture
Figure Parkinson's Disease Treatments Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Healthcare Institutes Picture
Figure Others Picture
Figure United States Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure France Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure UK Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure China Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure India Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Parkinson's Disease Treatments Revenue (Value) and Growth Rate (2013-2023)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Parkinson's Disease Treatments Type and Applications
Table GSK Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Parkinson's Disease Treatments Type and Applications
Table Merck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Parkinson's Disease Treatments Type and Applications
Table Novartis Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Parkinson's Disease Treatments Type and Applications
Table Teva Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Parkinson's Disease Treatments Type and Applications
Table Boehringer Ingelheim Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Impax Basic Information, Manufacturing Base and Competitors
Table Impax Parkinson's Disease Treatments Type and Applications
Table Impax Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Parkinson's Disease Treatments Type and Applications
Table Abbvie Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Parkinson's Disease Treatments Type and Applications
Table Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lundbeck Basic Information, Manufacturing Base and Competitors
Table Lundbeck Parkinson's Disease Treatments Type and Applications
Table Lundbeck Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Parkinson's Disease Treatments Type and Applications
Table Sun Pharma Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Parkinson's Disease Treatments Type and Applications
Table Wockhardt Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Acadia Basic Information, Manufacturing Base and Competitors
Table Acadia Parkinson's Disease Treatments Type and Applications
Table Acadia Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Parkinson's Disease Treatments Type and Applications
Table UCB Parkinson's Disease Treatments Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Parkinson's Disease Treatments Sales by Manufacturer (2016-2017)
Figure Global Parkinson's Disease Treatments Sales Market Share by Manufacturer in 2016
Figure Global Parkinson's Disease Treatments Sales Market Share by Manufacturer in 2017
Table Global Parkinson's Disease Treatments Revenue by Manufacturer (2016-2017)
Figure Global Parkinson's Disease Treatments Revenue Market Share by Manufacturer in 2016
Figure Global Parkinson's Disease Treatments Revenue Market Share by Manufacturer in 2017
Figure Top 3 Parkinson's Disease Treatments Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Parkinson's Disease Treatments Manufacturer (Revenue) Market Share in 2017
Figure Global Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Global Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatments Sales by Regions (2013-2018)
Table Global Parkinson's Disease Treatments Sales Market Share by Regions (2013-2018)
Table Global Parkinson's Disease Treatments Revenue by Regions (2013-2018)
Figure Global Parkinson's Disease Treatments Revenue Market Share by Regions in 2013
Figure Global Parkinson's Disease Treatments Revenue Market Share by Regions in 2017
Figure North America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure South America Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure North America Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table North America Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table North America Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatments Sales Market Share by Countries in 2013
Figure North America Parkinson's Disease Treatments Sales Market Share by Countries in 2017
Table North America Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Table North America Parkinson's Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatments Revenue Market Share by Countries in 2013
Figure North America Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure United States Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Canada Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Mexico Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Europe Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table Europe Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Table Europe Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatments Revenue Market Share by Countries in 2016
Figure Europe Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure Germany Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure UK Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure France Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Russia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Italy Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table Asia-Pacific Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Sales Market Share by Countries 2017
Table Asia-Pacific Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatments Revenue Market Share by Countries 2017
Figure China Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Japan Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Korea Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure India Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Southeast Asia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure South America Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table South America Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table South America Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatments Sales Market Share by Countries in 2017
Table South America Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Table South America Parkinson's Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure Brazil Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Argentina Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Colombia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatments Sales by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Countries in 2017
Table Middle East and Africa Parkinson's Disease Treatments Revenue by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries in 2013
Figure Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries in 2017
Figure Saudi Arabia Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure UAE Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Egypt Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure Nigeria Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Figure South Africa Parkinson's Disease Treatments Sales and Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatments Sales by Type (2013-2018)
Table Global Parkinson's Disease Treatments Sales Share by Type (2013-2018)
Table Global Parkinson's Disease Treatments Revenue by Type (2013-2018)
Table Global Parkinson's Disease Treatments Revenue Share by Type (2013-2018)
Figure Global Dopamine Agonists Sales Growth (2013-2018)
Figure Global Dopamine Agonists Price (2013-2018)
Figure Global Levodopa Sales Growth (2013-2018)
Figure Global Levodopa Price (2013-2018)
Figure Global Glutamate Antagonist Sales Growth (2013-2018)
Figure Global Glutamate Antagonist Price (2013-2018)
Figure Global Apomorphine Sales Growth (2013-2018)
Figure Global Apomorphine Price (2013-2018)
Figure Global COMT Inhibitors Anticholinergics Sales Growth (2013-2018)
Figure Global COMT Inhibitors Anticholinergics Price (2013-2018)
Figure Global MAO-B Inhibitors Sales Growth (2013-2018)
Figure Global MAO-B Inhibitors Price (2013-2018)
Figure Global Other Drugs Sales Growth (2013-2018)
Figure Global Other Drugs Price (2013-2018)
Table Global Parkinson's Disease Treatments Sales by Application (2013-2018)
Table Global Parkinson's Disease Treatments Sales Share by Application (2013-2018)
Figure Global Healthcare Institutes Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Parkinson's Disease Treatments Sales, Revenue and Growth Rate (2018-2023)
Table Global Parkinson's Disease Treatments Sales Forecast by Regions (2018-2023)
Table Global Parkinson's Disease Treatments Market Share Forecast by Regions (2018-2023)
Figure North America Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure Europe Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure Asia-Pacific Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure South America Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Figure Middle East and Africa Sales Parkinson's Disease Treatments Market Forecast (2018-2023)
Table Global Parkinson's Disease Treatments Sales Forecast by Type (2018-2023)
Table Global Parkinson's Disease Treatments Market Share Forecast by Type (2018-2023)
Table Global Parkinson's Disease Treatments Sales Forecast by Application (2018-2023)
Table Global Parkinson's Disease Treatments Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
